History
  • No items yet
midpage
Am. Hosp. Ass'n v. Azar
385 F. Supp. 3d 1
D.C. Cir.
2019
Read the full case

Background

  • Medicare Part B's OPPS sets prospective reimbursement rates for separately payable outpatient drugs (SCODs); default method is ASP plus 6% under 42 U.S.C. § 1395w-3a.
  • The 340B Program lets certain hospitals buy drugs at discounted acquisition prices; HHS sought to reduce the Medicare reimbursement for 340B-purchased drugs to narrow the spread.
  • For CY 2018 HHS set 340B drug payments to ASP minus 22.5%, citing lack of hospital acquisition-cost survey data and MedPAC estimates; plaintiffs challenged that rule in court.
  • The Court held the 2018 adjustment unlawful because the Secretary exceeded his statutory authority under § 1395l(t)(14)(A)(iii)(II), which permits only "adjustments" to ASP-based rates, not wholesale substitution of an acquisition-cost methodology.
  • HHS adopted the same ASP minus 22.5% approach for 2019; plaintiffs filed a supplemental complaint and moved for injunctive relief and other remedies for both years.
  • The Court again found the 2019 rate unlawful but declined to vacate the 2018 and 2019 OPPS rules; instead it remanded both rules to HHS without vacatur and retained jurisdiction to monitor progress.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether plaintiffs satisfied presentment and exhaustion under 42 U.S.C. § 405(g) to obtain judicial review Henry Ford presented claims for 2019 reimbursements; exhaustion is futile because issue is a pure legal question and administrative bodies cannot grant the relief requested Defendants did not contest presentment and argued exhaustion rules apply Court waived exhaustion as futile and exercised jurisdiction under § 405(g) because the challenge raises pure legal questions and administrative review cannot cure the legal error
Whether the Secretary exceeded statutory authority by setting 340B rates at ASP minus 22.5% under § 1395l(t)(14)(A)(iii)(II) The Secretary’s use of an acquisition-cost–based methodology and a ~30% reduction exceeds the limited "adjustment" authority and is ultra vires Secretary contends the action is an "adjustment" under subsection II and is within discretion; also asserted preclusion of review arguments Court held the adjustment was ultra vires: the Secretary fundamentally altered the statutory ASP-based scheme rather than making a permissible adjustment
Whether the agency action is committed to agency discretion or precluded from review Plaintiffs: statute limits adjustments and thus provides a judicially manageable standard Defendants: decisions on OPPS adjustments are committed to agency discretion and/or review is precluded by § 1395l(t)(12) Court found Amgen and related precedent supply a meaningful standard; preclusion/discretion defenses fail because the action was not a permissible "adjustment"
Appropriate remedy: vacatur, injunction, or remand Plaintiffs sought injunctions and retrospective payments (ASP plus 6%), including vacatur of the changes Defendants asked for remand without vacatur, leaving remedy to HHS Court remanded both rules to HHS without vacatur, denying full injunctive relief but granting relief in part; court retained jurisdiction and ordered status reports

Key Cases Cited

  • Amgen, Inc. v. Smith, 357 F.3d 103 (D.C. Cir. 2004) (limits on Secretary's authority to make "adjustments" to OPPS rates)
  • North Air Cargo v. USPS, 674 F.3d 852 (D.C. Cir. 2012) (district court generally remands unlawful agency action to the agency)
  • Bennett v. Donovan, 703 F.3d 582 (D.C. Cir. 2013) (agency should decide on remand how best to provide relief)
  • Allied-Signal, Inc. v. U.S. Nuclear Regulatory Comm'n, 988 F.2d 146 (D.C. Cir. 1993) (standard for vacatur: weigh seriousness of deficiencies against disruptive consequences)
  • Cape Cod Hosp. v. Sebelius, 630 F.3d 203 (D.C. Cir. 2011) (budget neutrality constraints and remedial adjustments in Medicare context)
  • Shands Jacksonville Med. Ctr. v. Burwell, 139 F. Supp. 3d 240 (D.D.C. 2015) (remand without vacatur appropriate where vacatur would create disruptive retroactivity and budget-neutrality issues)
  • H. Lee Moffitt Cancer Ctr. & Research Inst. Hosp., Inc. v. Azar, 324 F. Supp. 3d 1 (D.D.C. 2018) (remanding to HHS to adopt appropriate adjustment rather than ordering specific relief)
  • Bowen v. Georgetown Univ. Hosp., 488 U.S. 204 (U.S. 1988) (presumption against retroactive rulemaking)
Read the full case

Case Details

Case Name: Am. Hosp. Ass'n v. Azar
Court Name: Court of Appeals for the D.C. Circuit
Date Published: May 6, 2019
Citation: 385 F. Supp. 3d 1
Docket Number: Civil Action No.: 18-2084 (RC)
Court Abbreviation: D.C. Cir.